Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 28, 2003Critical CareOpen Access

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients

View Full Paper
Ask AI
Bookmark
Share

Authors

ΝΜΝικόλαος ΜάρκουHAH ApostolakosCKChristiana Koumoudiou

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Μάρκου et al. (2003) studied this question.

synapsesocial.com/papers/6a73798d77f4bbdd886c366fhttps://doi.org/10.1186/cc2358
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Impact of BAL Data on the Therapy and Outcome of Ventilator-Associated Pneumonia1997 · 924 citations
  2. 2Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance2001 · 38 citations
  3. 3A reassessment of the in-vitro activity of colistin sulphomethate sodium1997 · 140 citations
  4. 4Treatment of Multidrug‐Resistant<i>Acinetobacter baumannii</i>Ventilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP2003 · 475 citations
  5. 5In Vitro Pharmacodynamic Properties of Colistin and Colistin Methanesulfonate against <i>Pseudomonas aeruginosa</i> Isolates from Patients with Cystic Fibrosis2001 · 228 citations